Home › Funds › Penn Capital Management Company, LLC › TGTX

Penn Capital Management Company, LLC position in TGTX

TG THERAPEUTICS INC · Health Care

Penn Capital Management Company, LLC reported holding 480,881 shares of TGTX (TG THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$26.9M, representing 1.99% of its reported portfolio and ranking #3 among its reported holdings. Penn Capital Management Company, LLC has disclosed TGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)480.88K sh
Reported value held$26.88M
Portfolio Weight1.99%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Penn Capital Management Company, LLC's TGTX position evolved

Penn Capital Management Company, LLC first disclosed a stake in TGTX in Q4 2024 at 351,408 shares (US$10.6M). The position peaked in Q2 2026 at 536,067 shares, worth US$29.5M. Across 8 filings, Penn Capital Management Company, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 480,881 shares valued at US$26.9M — a reduction of -55,186 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 351.41K $10.58M New
Q1 2025 392.18K $15.51M Add
Q2 2025 443.37K $16.00M Add
Q3 2025 521.26K $18.88M Add
Q4 2025 538.12K $16.08M Add
Q1 2026 541.96K $18.05M Add
Q2 2026 536.07K $29.51M Reduce
Q3 2026 480.88K $26.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TGTX and 13F data

TGTX (TG THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in TGTX — the largest reported positions include Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Opaleye Management Inc. (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TGTX

All TGTX fund holders →

FAQ

How long has Penn Capital Management Company, LLC held TGTX?

Penn Capital Management Company, LLC has disclosed TGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Penn Capital Management Company, LLC's current position in TGTX?

As of Q3 2026, Penn Capital Management Company, LLC holds 480.88K shares of TGTX (TG THERAPEUTICS INC), valued at $26.88M, representing 1.99% of its reported portfolio and ranking #3.

Has Penn Capital Management Company, LLC been buying or selling TGTX?

In the latest 13F filing (Q3 2026), Penn Capital Management Company, LLC reduced its position in TGTX. The position peaked in Q2 2026 at 536.07K shares.

Which other funds hold TGTX?

Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Opaleye Management Inc., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.